One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients

Clinical Research in Cardiology

Volumn 102, Issue 7, 2013, Pages 505-511

  Schuchert, Andreas ^a   Muto, Carmine ^b   Maounis, Themistoklis ^c   Frank, Robert ^d   Ella, Rita Omega ^e   Polauck, Alexander ^f   Padeletti, Luigi ^g  

^a Friedrich Ebert Krankenhaus   (Germany)

^b Ospedale Loreto Mare   (Italy)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e St Jude Medical   (Belgium)

^f St Jude Medical   (Germany)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

CRT implantation; Mortality; NYHA functional class IV; Quality of life score; Severe end stage heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PRESCRIPTION; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84880308095     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0558-1     Document Type: Article

References (21)

1. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group (2009) Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 54(20):1837-46
2. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329-1338
3. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-defibrillation for ambulatory heart failure trial investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385-2395
4. Bristow MR, Saxon LA, Boehmer J, Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) investigators (2004) Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150
5. Cleland JGF, Daubert J-C, Erdmann E, Cardiac resynchronization heart failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl J Med 352:1539-49
6. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Tendera M, Anker SD, Blanc JJ, Gasparini M, Hoes AW, Israel CW, Kalarus Z, Merkely B, Swedberg K, Camm AJ (2010) Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12:1526-36
7. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M (2007) Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115:204-212
8. Castel MA, Magnani S, Mont L, Roig E, Tamborero D, Méndez-Zurita F, Femenia JF, Tolosana JM, Pérez-Villa F, Brugada J (2010) Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment. Europace 12:1136-1140
9. Vidal B, Delgado V, Mont L, Poyatos S, Silva E, Angeles Castel M, Tolosana JM, Berruezo A, Brugada J, Sitges M (2010) Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. Eur J Heart Fail 12:283-287
10. Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G (2008) Management of atrial fibrillation suppression in AF-HF comorbidity therapy study group. atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. Am Heart J 156:520-526
11. Lehmann MH, Aaronson KD (2006) CRT-D therapy in heart failure: how much do NYHA class IV patients benefit? J Cardiovasc Electrophysiol 17:491-494
12. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J (2009) The European cardiac resynchronization therapy survey. Eur Heart J 30:2450-2460
13. Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German competence network heart failure. Clin Res Cardiol 101(4):263-272. doi: 10.1007/s00392-011-0388-y
14. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101(1):1-10
15. Schuchert A (2005) Atrial fibrillation and heart failure comorbidity. Minerva Cardioangiol 53:299-311
16. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure. JACC 53:355-360
17. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, Verboven Y, Tavazzi L (2008) Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol 52:438-445
18. Bai R, di Biase L, Elayi C, Ching CK, Barrett C, Phillips K, Lim P, Patel D, Callahan T, Martin DO, Arruba M, Schweikert R, Saliba W, Wilkoff B, Natale A (2008) Mortality of heart failure after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol 19:1259-1265
19. van Bommel RJ, van Rijnsoever E, Borleffs CJ, Delgado V, Marsan NA, Bertini M, Schalij MJ, Bax JJ (2010) Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure. Am J Cardiol 106:1146-1151
20. Becker M, Erdmann N, Stegemann E, Benke D, Schauerte PN, Schaefer WM, Autschbach R, Kelm M, Koch KC (2008) Survival and quality of life in patients with cardiac resynchronization therapy for severe heart failure and in heart transplant recipients within a contemporary heart failure management program. J Heart Lung Transpl 27:746-752
21. Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS (2007) Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Am J Cardiol 100:90-93